Collegium Pharmaceutical
COLL
25,77 €
Share price
-0.52%
Change (1 day)
-13.33%
Change (1 year)
Categories
Collegium Pharmaceutical (COLL) - Total debt
Total debt on the balance sheet as of March 2025 : €0.71 Billion
According to Collegium Pharmaceutical 's latest financial reports the company's total debt is €0.71 Billion. A company’s total debt is the sum of all current and non-current debts.
Collegium Pharmaceutical - Total debt on balance sheet (from 2014 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | €0.82 B | 35.38% |
| 2023-12-31 | €0.60 B | -7.74% |
| 2022-12-31 | €0.66 B | 189.36% |
| 2021-12-31 | €0.22 B | 5.42% |
| 2020-12-31 | €0.21 B | 1024.36% |
| 2019-12-31 | €19.27 M | 91.76% |
| 2018-12-31 | €10.05 M | 715.52% |
| 2017-12-31 | €1.23 M | -68.73% |
| 2016-12-31 | €3.94 M | -36.74% |
| 2015-12-31 | €6.23 M | -41.74% |
| 2014-12-31 | €10.69 M | 1417.93% |
| 2013-12-31 | €0.7 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Agile Therapeutics
AGRX | €0.24 M | -99.97% | 🇺🇸 USA |
 Horizon Therapeutics
HZNP | €2.17 B | 202.94% | 🇮🇪 Ireland |
 United Therapeutics UTHR | €0.16 B | -76.31% | 🇺🇸 USA |
 KemPharm KMPH | €19.62 M | -97.26% | 🇺🇸 USA |